Completed PHASE1 INTERVENTIONAL 2-arm NCT04018339

A Study of RTA 402 in Obese Adults

Phase I Study of RTA 402 in Obese Adults

Sponsor: Kyowa Kirin Co., Ltd.

Interventions Bardoxolone methyl Placebo

Updated 6 times since 2019 Last updated: Jun 22, 2020 Started: Aug 20, 2019 Primary completion: May 28, 2020 Completion: Jun 18, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Obese Adult Male, this trial is completed. The trial is conducted by Kyowa Kirin Co., Ltd. and has accumulated 6 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jul 2020 — Jan 2021 [monthly]

Completed PHASE1

Status: Recruiting → Completed
Mar 2020 — Jul 2020 [monthly]

Recruiting PHASE1

▶ Show 1 earlier version

Aug 2019 — Mar 2020 [monthly]

Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kyowa Kirin Co., Ltd.

Data source: Kyowa Kirin Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kurume, Japan